FPAW from Trachinotus ovatus Attenuates Potassium-Oxonate-Induced Hyperuricemia in Mice via Xanthine Oxidase Inhibition and Gut Microbiota Modulation: Molecular Insights and In Vivo Efficacy
Nutrients · 2025
DOI: 10.3390/nu17111831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Huan Xiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Aquatic Product Processing, Ministry of Agriculture and Rural Affairs, National R&D Center for Aquatic Product Processing, South Ch…. Hauptthemen laut MEDLINE: Hyperuricemia, Xanthine Oxidase, Gastrointestinal Microbiome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Province Marine Economy Development Special Project, Natural Science Foundation of Hainan Provincial, Central Public-interest Scientific Institution Basal Research Fund.
Abstract (Originalsprache)
Background
Hyperuricemia (HUA) is a widespread metabolic disorder that arises from disruptions in purine metabolism, impaired kidney function, or both conditions. FPAW (Phe-Pro-Ala-Trp) is a novel peptide identified from Trachinotus ovatus with great XOD (xanthine oxidase) inhibitory activity (IC50 = 3.81 mM), which can be developed as a potential active ingredient to relieve hyperuricemia. However, it remains unclear whether FPAW alleviates HUA in vivo or not.
Methods
In this study, potassium-oxonate-induced hyperuricemic mice were used to evaluate the in vivo anti-hyperuricemic activity of FPAW. Some physiological parameters, such as serum uric acid (SUA), serum creatinine (SCR), blood urea nitrogen (BUN), and the activity of XOD and ADA (adenosine deaminase) in the liver were determined to evaluate the effect of reduced uric acid. The modulations in the gut microbiota and its metabolites (SCFAs) were analyzed by sequencing the V3-V4 region of the 16S rRNA gene and GC-MS in different fecal samples. Molecular docking was used to predict the interactions between the enzymes and FPAW.
Results
The results showed that FPAW reduced the levels of serum uric acid, serum creatinine, and blood urea nitrogen, while also suppressing the activity of XOD in the livers of HUA mice. Moreover, the FPAW treatment alleviated gut microbiota dysfunction and increased the production of short-chain fatty acids to protect normal intestinal function and health of the host. Molecular docking simulations revealed that FPAW inhibited XOD activity by entering the hydrophobic channel and interacting with amino acid residues on the surface via hydrogen bonding and hydrophobic interactions.
Conclusions
This study provides new candidates for the development of hypouricemic drugs. FPAW exhibited great potential to relieve hyperuricemia of mice induced by diet in the animal experiment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Aquatic Product Processing, Ministry of Agriculture and Rural Affairs, National R&D Center for Aquatic Product Processing, South China Sea Fisheries Research Institute, Chinese Academy of Fishery Scien…
- Key Laboratory of Efficient Utilization and Processing of Marine Fishery Resources of Hainan Province, Sanya Tropical Fisheries Research Institute, Sanya 572018, China.
- School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1010, New Zealand.
ORCID-Profile: Shengjun Chen, Yanyan Wu, Yongqiang Zhao
Förderung
- Guangdong Province Marine Economy Development Special Project
- Natural Science Foundation of Hainan Provincial
- Central Public-interest Scientific Institution Basal Research Fund
- CARS
- International Scientific and Technological Cooperation Research and Development Program of Hainan Province
- National Key R&D Program of China
- Central Public-interest Scientific Institution Basal Research Fund, CAFS
Zitieren
APA
Xiang, H., Sun-Waterhouse, D., Hu, X., Hou, M., Chen, S., Wu, Y., Zhao, Y., & Wang, Y. (2025). FPAW from Trachinotus ovatus Attenuates Potassium-Oxonate-Induced Hyperuricemia in Mice via Xanthine Oxidase Inhibition and Gut Microbiota Modulation: Molecular Insights and In Vivo Efficacy. Nutrients. https://doi.org/10.3390/nu17111831
Vancouver
Xiang H, Sun-Waterhouse D, Hu X, Hou M, Chen S, Wu Y, et al. FPAW from Trachinotus ovatus Attenuates Potassium-Oxonate-Induced Hyperuricemia in Mice via Xanthine Oxidase Inhibition and Gut Microbiota Modulation: Molecular Insights and In Vivo Efficacy. Nutrients. 2025. doi:10.3390/nu17111831
BibTeX
@article{Xiang2025,
author = {Xiang, Huan and Sun-Waterhouse, Dongxiao and Hu, Xiao and Hou, Mengfan and Chen, Shengjun and Wu, Yanyan and Zhao, Yongqiang and Wang, Yueqi},
title = {FPAW from Trachinotus ovatus Attenuates Potassium-Oxonate-Induced Hyperuricemia in Mice via Xanthine Oxidase Inhibition and Gut Microbiota Modulation: Molecular Insights and In Vivo Efficacy},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17111831}
}
EUVIMED